We characterized the genomic variation of adenovirus type 5 isolates recovered from bone marrow transplant recipients in Seattle between 1976 and 1982. By restriction endonuclease analysis, we identified three new adenovirus genomic variants, each associated with a single invasive adenovirus infection. In addition, we were able to obtain suggestive evidence for a nosocomial spread of a particular group of isolates within this population. This study demonstrates that the technique of restriction endonuclease analysis is an important epidemiological tool for investigating viral infections.
A systematic review of adenovirus infections occurring after bone marrow transplantation in Seattle over a 6-year period showed an overall incidence of adenovirus infection of at least 4.9% (8) . The distribution of adenovirus types (or species) found in these patients was distinct from that found in community surveys, showing a higher proportion of adenovirus type 5 (Ad5) (subgenus C) and a group of the closely related Adll, Ad34, and Ad35 (subgenus B) in the bone marrow transplant patients. It was felt that the source of infection in most cases was endogenous viral reactivation as a result of posttransplant immunosuppression.
We now report the molecular characterization (as determined by restriction endonuclease analysis) of the Ad5 isolates obtained from these marrow transplant patients and relate these findings to the clinical illnesses present.
MATERIALS AND METHODS
The population of patients studied, as well as the methods and materials used for pathological and virological analysis, has previously been described (8) . Viral stocks were frozen at -70°C. DNA analysis was performed as previously described (5) . Briefly, virus was grown in 1-cm2 wells of confluent HeLa cells until the cytopathic effect was extensive. Viral DNA was extracted from the infected cells by a modification (9) of the Hirt procedure (6). The Ad5infections (8) . Among the other four patients not included in the analysis, three had been typed initially by neutralization and were no longer available for DNA analysis, and the remaining patient had two distinct types (Ad2 and Ad5) that were identified from the same specimen.
Type determination was initially made by microneutralization analysis as previously described (5, 8) and confirmed by the restriction endonuclease cleavage patterns generated by SmaI digestion. All 14 isolates showed SmaI digestion patterns identical to that of the Ad5 prototype (Table 1) . Five isolates showed digestion patterns similar to that of prototype Ad5 for each of four additional restriction endonucleases (EcoRI, HpaI, HindIII, and KpnI). The seven isolates of group 2, designated the major variant group, all showed an aberrant cleavage pattern for each of these latter four enzymes. Two other isolates differed in cleavage patterns from both those of the prototype and major variant and were different from each other ( Table 1 ; Fig. 1 ).
Also summarized in Table 1 [8] ) had invasive adenovirus infections, and the virus isolated from each showed one of the variant patterns described. All three patients died from pneumonia; the patients from whom Ad5c Whether adenovirus contributed to the pneumonia and subsequent death of the patient is uncertain. All patients in the study received similar types of immunosuppressive drugs, although several different protocols were used. Levels of immunosuppression among patients with invasive adenovirus infections appeared comparable to those of patients without invasive adenovirus infections.
Also, there appeared to be essentially no difference in the degree of immunosuppression between the five patients with prototype Ad5 isolated and the nine patients with Ad5 genomic variants isolated.
All five patients whose isolates had enzyme patterns similar to that of prototype Ad5 had adenovirus that was first isolated over a 15-day period in late February and early March 1982. These five patients were all hospitalized at the Fred Hutchinson Cancer Research Center for various periods between December 1981 and April 1982. At no time during the 5-month period were all five patients hospitalized at the same time, but before and during the 15-day period, all were seen by many of the same staff members. Three of these patients had viruses that were isolated during hospitalization, and the other two were tested as outpatients. The timing of the isolates and hospitalizations is shown in Fig. 3 .
DISCUSSION
We have identified nine human adenovirus isolates from bone marrow transplant recipients which have neutralization antibody patterns typical of Ad5 but whose restriction endonuclease cleavage patterns are heterogeneous and distinct from those of prototype Ad5. These isolates fall into one major and two minor groups that differ from the isolates of prototype Ad5 with respect to the patterns of three or more enzymes in different regions of the genome; the nine isolates also appear distinct from Ad5a. We propose that these new isolates be designated genome types 5b, 5c, and 5d as defined by the maps shown in Fig. 2 and the letters to the right of the gels refer to the fragment designations for prototype Ad5 (for comparisons between prototype and variants). The HindIII digests show a loss of the D fragment in Ad5b, Ad5c, and Ad5d (due to the presence of an additional cleavage site); the HpaI digests also show a loss of the D fragment in the three genomic variants (due to an additional cleavage site) and displacement of the B fragment downward in Ad5c due to a change in the cleavage site between the B and F fragments (producing a smaller-molecular-weight B fragment); the KpnI digests show the displacement of the C fragment upward (higher molecular weight) in Ad5b, Ad5c, and Ad5d due to loss of the cleavage site between the C and I fragments. In addition, Ad5d shows an A fragment of higher molecular weight due to loss of a cleavage site between the A and H fragments. bronchopenumonia, and occurred primarily in younger patients (mean age, 4.5 years). The restriction endonuclease analysis of the Ad5a isolates differed from that of the Ad5 prototype with respect to three restriction endonucleases. BamHI yielded two additional cleavage sites, whereas HindIII and Hpal each yielded one extra site. The Ad5a digestion patterns for HindIII appeared identical to those for our new variants Ad5b and Ad5d but distinct from Ad5c. The Ad5a HpaI digestion pattern appeared identical to those for Ad5b, Ad5c, and Ad5d. The BamHI pattern for Ad5a was distinct from those of our new variants.
There is no well-established definition of a genome type or variant of adenovirus. We previously elected to use the criterion (as for the Adl and Ad2 genomic variants previously described [4] ) that "changes in the cleavage patterns must be demonstrable for two or more restriction endonuclease cleavage sites that are separated by more than 1% of the genome" (4). The previously described variant (Ad5a) for Ad5 fulfills this criterion, as do our three newly described variants when compared with prototype Ad5, although Ad5d differs from type Ad5b only by the addition of one KpnI cleavage site (Fig. 2) and thus could be considered as a minor variant of Ad5b.
The identification of genomic variants of adenovirus is important for two reasons. First, the DNA cleavage patterns can be used as strain markers in epidemiological studies, as previously described by Wadell et al. (12, 13) 2, 7, 10, 11, 14) . The most recent and best documented study was by Straube and colleagues (11) , who reported an outbreak of Ad7b in a hospital for children in San Diego, California, in 1980. Four of six patients infected with Ad7b died, and all had underlying respiratory disease.
All 11 hospital employees from whom Ad7 was cultured were nurses working in a unit with an infected patient. A large number of employees developed clinical illness, including all 11 with positive cultures.
In conclusion, we have characterized three new Ad5 genomic variants recovered from bone marrow transplant recipients. Each of these variants was associated with an invasive adenovirus infection, and it is postulated that these variations in the Ad5 genome may be related to virulence, at least in an immunocompromised host.
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